Journal
PAIN MEDICINE
Volume 9, Issue 3, Pages 348-353Publisher
OXFORD UNIV PRESS
DOI: 10.1111/j.1526-4637.2006.00196.x
Keywords
herpes zoster; postherpetic neuralgia; health care expenditures; cost-effectiveness; treatment; prevention
Categories
Funding
- NIA NIH HHS [T32-AG020493-02] Funding Source: Medline
Ask authors/readers for more resources
Objectives. Pain can persist long after the resolution of herpes zoster, but little is known regarding its health care costs. The objective of this study was to determine the health care expenditures associated with persisting pain following herpes zoster by comparing expenditures for patients with postherpetic neuralgia or subacute herpetic neuralgia with a control group without these conditions. Methods. Health care expenditures attributable to persisting pain in herpes zoster patients were calculated using Thomson-Medstat's MarketScan (R) databases to examine commercial, Medicare, and Medicaid claims for inpatient and outpatient services and outpatient prescription drugs. Results. Excess annualized costs were $4,917 for commercially insured patients, $2,696 for Medicare patients, and $9,310 for Medicaid patients. Conclusions. The substantial health care costs associated with persisting pain in herpes zoster have important public health implications given evidence that the incidence of herpes zoster is increasing and that the population is aging in the United States. The results provide a basis for evaluating the cost-effectiveness of existing treatments and emerging prevention strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available